Spots Global Cancer Trial Database for endometrial papillary serous carcinoma
Every month we try and update this database with for endometrial papillary serous carcinoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer | NCT00003749 | Endometrial Can... | adjuvant therap... conventional su... brachytherapy radiation thera... | - | National Cancer Institute (NCI) | |
Comparison of Radiation Therapy With or Without Combination Chemotherapy Following Surgery in Treating Patients With Stage I or Stage II Endometrial Cancer | NCT00006027 | Endometrial Can... | cisplatin paclitaxel adjuvant therap... radiation thera... | 18 Years - 120 Years | Radiation Therapy Oncology Group | |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | NCT00002493 | Endometrial Can... Psychosocial Ef... | cisplatin doxorubicin hyd... low-LET photon ... | - | GOG Foundation | |
Radiation Therapy With or Without Chemotherapy in Treating Patients With High-Risk Endometrial Cancer | NCT00005583 | Endometrial Can... | cisplatin doxorubicin hyd... epirubicin hydr... adjuvant therap... conventional su... radiation thera... | - | National Cancer Institute (NCI) | |
Paclitaxel in Treating Patients With Refractory or Recurrent Endometrial Cancer | NCT00022620 | Endometrial Can... | paclitaxel | - 75 Years | European Organisation for Research and Treatment of Cancer - EORTC | |
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer | NCT00025467 | Endometrial Ade... Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... | thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
Temsirolimus in Treating Patients With Metastatic or Locally Advanced Recurrent Endometrial Cancer | NCT00072176 | Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... Stage IIIA Endo... Stage IIIB Endo... Stage IIIC Endo... Stage IVA Endom... Stage IVB Endom... | temsirolimus laboratory biom... | 18 Years - | National Cancer Institute (NCI) | |
Surgery With or Without Lymphadenectomy and Radiation Therapy in Treating Patients With Endometrial Cancer | NCT00003749 | Endometrial Can... | adjuvant therap... conventional su... brachytherapy radiation thera... | - | National Cancer Institute (NCI) | |
Role of Biomarkers in Endometrial Cancer Recurrence in Samples From Patients With Stage II, Stage III, or Stage IV Endometrial Cancer | NCT01150682 | Endometrial Can... | RNA analysis reverse transcr... enzyme-linked i... immunohistochem... laboratory biom... | - | National Cancer Institute (NCI) | |
Thalidomide in Treating Patients With Recurrent or Persistent Endometrial Cancer | NCT00025467 | Endometrial Ade... Endometrial Ade... Endometrial Ade... Endometrial Cle... Endometrial Pap... Recurrent Endom... | thalidomide laboratory biom... | - | National Cancer Institute (NCI) | |
Radiation Therapy Compared With Combination Chemotherapy in Treating Patients With Advanced Endometrial Cancer | NCT00002493 | Endometrial Can... Psychosocial Ef... | cisplatin doxorubicin hyd... low-LET photon ... | - | GOG Foundation |